IRIS
VILLANI, ALESSIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.733
AS - Asia 762
EU - Europa 672
AF - Africa 37
SA - Sud America 3
OC - Oceania 2
Continente sconosciuto - Info sul continente non disponibili 1
Totale 3.210
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.710
SG - Singapore 398
IT - Italia 350
HK - Hong Kong 236
NL - Olanda 109
CN - Cina 94
DE - Germania 61
FI - Finlandia 32
CI - Costa d'Avorio 30
SE - Svezia 24
CA - Canada 18
IE - Irlanda 18
RU - Federazione Russa 17
GB - Regno Unito 14
FR - Francia 11
IN - India 11
UA - Ucraina 7
EG - Egitto 6
BG - Bulgaria 5
MX - Messico 5
RO - Romania 5
VN - Vietnam 5
CZ - Repubblica Ceca 3
JP - Giappone 3
PL - Polonia 3
TW - Taiwan 3
AE - Emirati Arabi Uniti 2
AU - Australia 2
BE - Belgio 2
CL - Cile 2
DK - Danimarca 2
EE - Estonia 2
HU - Ungheria 2
IR - Iran 2
KR - Corea 2
TH - Thailandia 2
AL - Albania 1
BR - Brasile 1
CH - Svizzera 1
ES - Italia 1
EU - Europa 1
IL - Israele 1
KZ - Kazakistan 1
LU - Lussemburgo 1
LV - Lettonia 1
MY - Malesia 1
NG - Nigeria 1
PK - Pakistan 1
Totale 3.210
Salva come PNG Salva come JPEG
Città #
Singapore 329
Chandler 321
Santa Clara 262
Hong Kong 236
Ashburn 125
Amsterdam 102
Lawrence 81
Napoli 76
Boston 74
Millbury 70
Des Moines 46
Naples 36
Wilmington 30
Beijing 29
Rome 25
Milan 22
Nanjing 21
Washington 20
Seattle 19
Kronberg 15
Lappeenranta 15
Helsinki 14
Los Angeles 12
Ottawa 11
Dublin 10
Fairfield 9
Falkenstein 9
Latina 9
Cagliari 8
Turin 7
Woodbridge 7
Cairo 6
Houston 6
Princeton 6
Dallas 5
Grammichele 5
Hebei 5
Pune 5
Afragola 4
Dong Ket 4
Frankfurt am Main 4
Freiburg im Breisgau 4
Jiaxing 4
Krefeld 4
Meppel 4
Mexico City 4
Moscow 4
Paris 4
The Dalles 4
Avella 3
Boardman 3
Changsha 3
Edinburgh 3
Florence 3
Jacksonville 3
Kagoya 3
Magenta 3
Nanchang 3
Padova 3
Prague 3
Santa Maria La Carita 3
Shenyang 3
Sofia 3
Taipei 3
Warsaw 3
Ann Arbor 2
Arezzo 2
Asti 2
Bergamo 2
Bisceglie 2
Bologna 2
Brussels 2
Budapest 2
Buffalo 2
Burgas 2
Carugate 2
Castellammare di Stabia 2
Chengdu 2
Copenhagen 2
Council Bluffs 2
Dubai 2
Fragagnano 2
Frattamaggiore 2
Giugliano in Campania 2
Golasecca 2
Imola 2
Lecce 2
Macerata 2
Modena 2
Munich 2
New York 2
Norwalk 2
Orta Nova 2
Palermo 2
Perugia 2
Piano di Conca 2
Redwood City 2
Santiago 2
Sarno 2
Selargius 2
Totale 2.250
Salva come PNG Salva come JPEG
Nome #
Review of oral minoxidil as treatment of hair disorders: in search of the perfect dose 144
A case of the co-existence of subcorneal pustular dermatosis and pyoderma gangrenosum and a review of the literature 59
Clinical and dermoscopic features of Spitz nevus by sex, age and anatomical site: a study of 913 Spitz naevi 56
Psoriasis in a cohort of patients with common variable immunodeficiency 53
Cutaneous leucocytoclastic vasculitis during secukinumab treatment 52
Complete remission of an advanced basal cell carcinoma after only 3-month treatment with sonidegib: Report of a case and drug management during COVID-19 pandemic 50
Advanced basal cell carcinoma treated with vismodegib: impact on the lives of patients and their families 48
Reply to Woltsche N. et al. Managing adverse effects by dose reduction during routine treatment of locally advanced basal cell carcinoma with the hedgehog inhibitor vismodegib: a single center experience 47
Squamous Cell Carcinomas in Two Cases of Nail Lichen Planus: Is There a Real Association? 47
How reflectance confocal microscopy can help diagnose an enigmatic variant of dermatofibroma 47
Adalimumab versus Rifampicin Plus Clindamycin for the Treatment of Moderate to Severe Hidradenitis Suppurativa: A Retrospective Study 46
Vismodegib treatment in a HIV positive patient on antiretroviral therapy 44
Teledermoscopy: a promising tool in pediatric practice 43
Long-Term Efficacy of Vismodegib After its Withdrawal and Patients’ Health-Related Quality of Life Using the Dermatology Life Quality Index (DLQI) 41
Leiomyoma of the finger in a patient affected by cutaneous Kaposi's sarcoma 41
Effective and tolerable treatment of advanced basal cell carcinoma with vismodegib despite other malignancies 41
Efficacy and safety of a new topical gel formulation containing retinol encapsulated in glycospheres and hydroxypinacolone retinoate, an antimicrobial peptide, salicylic acid, glycolic acid and niacinamide for the treatment of mild acne: preliminary results of a 2-month prospective study 41
Cutaneous Bowen’s disease: An analysis of 182 cases according to age, sex, and anatomical site from an Italian center 39
Merkel Cell Carcinoma: Therapeutic Update and Emerging Therapies 38
Letter to the editor submitted in response to "psoriasis in pregnancy: case series and literature review of data concerning exposure during pregnancy to ustekinumab" 37
Alopecia universalis improvement following risankizumab in a psoriasis patient 37
Psoriasis Features in Patients with Inflammatory Bowel Disease 36
Dermoscopic patterns of intradermal naevi 36
Low-Dose Vismodegib as Maintenance Therapy After Locally Advanced Basal Cell Carcinoma Complete Remission: High Efficacy with Minimal Toxicity 36
Grover disease in a young woman: report of case. 36
Use of Natural Agents and Agrifood Wastes for the Treatment of Skin Photoaging 35
Reply to Wong C et al. "Comparison of daily dosing vs. Monday through Friday dosing of vismodegib for locally advanced basal cell carcinoma (laBCC) and basal cell nevus syndrome: a retrospective case series" 35
Efficacy and safety of vismodegib in patients with basal cell carcinoma: An Italian Center experience 35
The effectiveness of vismodegib in patients with advanced periocular basal cell carcinoma: a case series of 13 patients 35
Patients with bullous disorders during COVID-19 period: Management and adherence to treatment 35
Assessment of the adverse events related to hedgehog pathway inhibitor therapy for basal cell carcinoma: A single-centre retrospective study 35
It Is Not as It Seems 34
Dermoscopic assessment of long-term systemic therapy with dupilumab in adult atopic dermatitis 34
Teledermatology for acne during COVID-19: high patients' satisfaction in spite of the emergency 32
Dermoscopy and reflectance confocal microscopy of Kaposi's sarcoma: an overview 32
Efficacy and safety of ustekinumab in a group of 22 elderly patients with psoriasis over a 2-year period 31
The remarkable increase of squamous cell carcinomas: a retrospective single-center study of 14-years study period 31
Neutrophilic dermatosis in pregnancy: An uncommon course 31
Reflectance confocal microscopy for Kaposi's sarcoma treatment monitoring after intralesional vincristine chemotherapy 31
Effects of COVID-19 pandemic on malignant melanoma diagnosis 30
Cutaneous melanoma associated with naevi prevalence: A 15-year cross-sectional retrospective study 30
Nail changes as manifestation of systemic disease in COVID‐19 infection 30
Awareness on sun protection behavior among melanoma and nonmelanoma skin cancer patients: An Italian tertiary cancer center experience 30
Systemic Treatment of Pediatric Psoriasis: A Review. 29
Real-Life Effectiveness of Vismodegib in Patients with Metastatic and Advanced Basal Cell Carcinoma: Characterization of Adverse Events and Assessment of Health-Related Quality of Life using the Dermatology Life Quality Index (DLQI) Test 28
The Role of Teledermatology During the COVID-19 Pandemic: A Narrative Review 27
COVID-19 and cutaneous manifestations: A review of the published literature 27
Tinea Capitis in Campania: A 5-Year Retrospective Study in Childhood and Adolescence (2013-2018). 27
Therapeutic update of biologics and small molecules for scalp psoriasis: a systematic review 27
Teledermatology and chronic skin diseases: real life experience in a Southern Italian Dermatologic Centre 26
Dermatophytid evaluated by in vivo reflectance confocal microscopy: a new approach? 26
Teledermatology: a useful tool also after Covid-19 era? 26
COVID-19 vaccination and inflammatory skin diseases 26
The Impact of COVID-19 Vaccination on Inflammatory Skin Disorders and Other Cutaneous Diseases: A Review of the Published Literature 25
Teledermatology for acne patients: How to reduce face-to-face visits during COVID-19 pandemic 25
Letter to the editor regarding article "Falotico JM, Gu L, Lipner SR. Not just pimple popping: The utility of hybrid telemedicine models beyond acne management amidst the ongoing COVID-19 pandemic. J Cosmet Dermatol. 2022;10.1111/jocd.15256" 24
Phototherapy and vitamin D: the importance in COVID-19 era 24
Comment on: “Second primary melanomas in a cohort of 977 melanoma patients within the first 5 years of monitoring” 24
Community Knowledge About the Use, Reuse, Disinfection and Disposal of Masks and Filtering Facepiece Respirators: Results of a Study Conducted in a Dermatology Clinic at the University of Naples in Italy 24
Long-term results of teledermatology for acne patients during COVID-19 pandemic 24
Adalimumab biosimilar in a pediatric patient: clinical and in vivo reflectance confocal microscopy evaluation 23
Reply to ‘Impact of the French COVID ‐19 pandemic lockdown on newly diagnosed melanoma delay and severity’ by R. Molinier et al 23
Oral isotretinoin for acne: a complete overview 23
Viral Reactivation Following COVID-19 Vaccination: a review of the current literature 23
Teledermatology in the management of hidradenitis suppurativa: Should we improve this service? 22
Systemic Treatment of Adult Atopic Dermatitis: A Review 22
Dose reduction during routine treatment of locally advanced basal cell carcinoma with the hedgehog inhibitor sonidegib to manage adverse effects: A retrospective case series 22
Telemedicine and support groups could be used to improve adherence to treatment and health-related quality of life in patients affected by inflammatory skin conditions during the COVID-19 pandemic 22
Maskne prevalence and risk factors during the COVID-19 pandemic 21
Patient satisfaction with remote dermatology consultations during the COVID-19 pandemic. Comment on 'A qualitative assessment of patient satisfaction with remote dermatology consultations used during the UK's first wave of the COVID-19 pandemic in a single, secondary-care dermatology department' 21
Reply to 'Cutaneous adverse effects of the available COVID-19 vaccines in India: A questionnaire-based study' by Bawane J et al 21
Sonidegib: Safety and Efficacy in Treatment of Advanced Basal Cell Carcinoma 21
Cemiplimab for the treatment of advanced cutaneous squamous cell carcinoma 21
Herpes Zoster and COVID-19 Vaccination: A Narrative Review 19
Second primary melanoma: incidence rate and risk factors 19
Long-term efficacy of telemedicine for patients with locally advanced basal cell carcinoma during COVID-19 pandemic 18
Cutaneous adverse reaction following COVID-19 vaccination: Report from a southern Italian referral centre. Comment on "cutaneous adverse reactions following the Pfizer/BioNTech COVID-19 vaccine" by Luo et al 18
The impact of COVID-19 pandemic on nonmelanoma skin cancers: report of a Southern Italy referral centre 18
The reduction in the detection of melanoma during the coronavirus disease 2019 (COVID-19) pandemic in a melanoma center of South Italy 18
Micro needling: A novel therapeutic approach for androgenetic alopecia, A Review of Literature 18
Psoriasis awareness among general population: preliminary results of an online survey 18
Trends in epidemiology of melanoma in situ in a center of South-Italy: Data from a melanoma reference center during the period 2004–2018 18
Letter to the editor regarding article "Hlaca N, Zagar T, Kastelan M, Peternel S, Brajac I, Prpic-Massari L. New-onset lichen planus and lichen planus flare in elderly women after COVID-19 vaccination. J Cosmet Dermatol. 2022;10.1111/jocd.15185" 17
Advanced Squamous Cell Carcinoma Developed on Chronic Hidradenitis Suppurativa, Successfully Treated with Cemiplimab: A Case Report 17
Hedgehog inhibitors in the treatment of advanced basal cell carcinoma: risks and benefits 17
Looking into a Better Future: Novel Therapies for Metastatic Melanoma 17
Resistance to hedgehog inhibitors in basal cell carcinoma: strategies to adopt 17
Efficacy and safety of sonidegib for the management of basal cell carcinoma: a drug safety evaluation 16
Adalimumab, Ustekinumab, and Secukinumab in the Management of Hidradenitis Suppurativa: A Review of the Real-Life Experience 16
Comment on: “Clinical characteristics of patients with pityriasis rubra pilaris following SARS‐CoV‐2 vaccination” by Gambichler 16
Response to "Efficacy of sonidegib in histologic subtypes of advanced basal cell carcinoma: Results from the final analysis of the randomized phase 2 Basal Cell Carcinoma Outcomes with LDE225 Treatment (BOLT) trial at 42 months" 16
Development of a Patient-Reported Outcome Measure (PROM) for Dysgeusia During Treatment With Smoothened (SMO) Inhibitors for Basal Cell Carcinomas: The SMO-iD Questionnaire 15
ChatGPT and Dermatology: friends or foes? 15
Author Reply to “Comment on ChatGPT and Medical Writing in Dermatology: why should we keep writing?” by Daungsupawong et al 15
Teledermatology for Common Inflammatory Skin Conditions: The Medicine of the Future? 15
Patients with advanced basal cell carcinomas in treatment with sonic hedgehog inhibitors during the coronavirus disease 2019 (COVID-19) period: Management and adherence to treatment 15
Melanoma Screening Days During the Coronavirus Disease 2019 (COVID-19) Pandemic: Strategies to Adopt 15
Author Reply to “Comment on ChatGPT and Medical Writing in Dermatology: why should we keep writing?” by Duff et al 14
Unaddressed Challenges in the Treatment of Cutaneous Melanoma? 14
Cutaneous reactions following booster dose of Covid-19 mRNA vaccination: what we should know 14
Totale 2.950
Salva come PNG Salva come JPEG
Categoria #
all - tutte 19.758
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 19.758
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202071 0 0 0 0 0 0 3 0 7 14 35 12
2020/2021198 10 0 9 12 19 7 2 74 3 50 8 4
2021/2022415 0 0 4 2 2 20 18 18 17 35 99 200
2022/2023765 102 76 19 34 104 68 7 80 115 95 41 24
2023/2024728 28 105 65 37 41 87 10 67 34 28 138 88
2024/20251.135 210 225 31 46 116 250 257 0 0 0 0 0
Totale 3.418